• Insomnia severity in migraine: The role of headache frequency, aura status, and comorbidities-A cross-sectional study
  Headache. 2025 Sep 19.

• Candesartan for Treatment of Migraine Headache: A Scoping Review

  Clin Ther. 2025 Jun 25:S0149-2918(25)00207-3.

• A dilemma in pediatric migraine: Headache or school performance? – A comparison of topiramate and flunarizine

  Brain Dev. 2025 Jul 3;47(4):104390.

• Hypokalemia in chronic migraine with medication overuse headache: a retrospective cross-sectional study

  BMC Neurol. 2025 Jul 1;25(1):265.

• Risk of stroke, myocardial infarction, coronary intervention, and atrial fibrillation or flutter in individuals experiencing typical migraine aura without headache: a Danish registry-based cohort study

  Int J Epidemiol. 2025 Jun 11;54(4):dyaf079.

• Beyond the Headache: Autonomic Reflex Dysfunction and Sensory Hypersensitivity Contribute to Orthostatic Intolerance in Migraine

  Res Sq.[Preprint]. 2025 Jun 16:rs.3.rs-6847469.

• Update on Neuromodulation for Migraine and Other Primary Headache Disorders: Recent Advances and New Indications

  Curr Pain Headache Rep. 2025 Feb 15;29(1):47.

• Migraine is more than a headache – a radical rethink offers hope to one billion people

  Nature. 2025 Feb;638(8051):600-602.

• Setting higher standards for migraine prevention: A position statement of the International Headache Society

  Cephalalgia. 2025 Feb;45(2):3331024251320608.

• Association between headache laterality in migraine and hemispheric distribution of white matter hyperintensities on MRI

  J Neurol. 2024 Dec 12;272(1):18.

• Eptinezumab treatment was associated with longer interictal headache/migraine periods which corresponded to greater improvements in patient-reported quality of life measures

  J Neurol. 2024 Dec 12;272(1):4.

• Association between dietary folate intake and severe headache or migraine in adults: a cross-sectional study of the National Health and Nutrition Examination Survey

  Front Nutr. 2024 Nov 26:11:1456502.

• Effect of preventive treatment with atogepant on quality of life, daily functioning, and headache impact across the spectrum of migraine: Findings from three double-blind, randomized, phase 3 trials

  . 2024 Dec;44(12):3331024241300305.

• Effects of probiotic and vitamin D co-supplementation on clinical symptoms, mental health, and inflammation in adult patients with migraine headache: a randomized, triple-blinded, placebo-controlled trial

  BMC Med. 2024 Oct 11;22(1):457.

• Efficacy and Tolerability of Anti-CGRP Monoclonal Antibodies in Patients Aged ≥ 65 Years With Daily or Nondaily Migraine

Neurology Clinical Practice. February 2025.

• A Monoclonal Antibody to PACAP for Migraine Prevention

  N Engl J Med. 2024 Sep 5;391(9):800-809.

• Relationship between migraine and epilepsy in a large population-based cohort: The HUNT Study

  Eur J Neurol. 2024 Sep 27:e16496.

• What Is Combination Treatment in Migraine? Moving Toward a Uniform Definition of a Familiar Principle

  Neurol Ther. 2024 Oct 15.

• International Headache Society global practice recommendations for the acute pharmacological treatment of migraine

  Cephalalgia. 2024 Aug;44(8):3331024241252666.

• Female sexual dysfunction and distress in premenopausal women with migraine followed in a tertiary headache center: A pilot study

  Clin Neurol Neurosurg. 2024 Aug 3:245:108476

  ---

• Open label experience of repeated OnabotulinumtoxinA injections towards the sphenopalatine ganglion in patients with chronic cluster headache and chronic migrain

  Cephalalgia. 2024. Aug;44(8):3331024241273967.

  ---

• Persistent effectiveness of CGRP antibody therapy in migraine and comorbid medication overuse or medication overuse headache – a retrospective real-world analysis

  J Headache Pain. 2024 Jul 4;25(1):109.

• Association of dietary vitamin C consumption with severe headache or migraine among adults: a cross-sectional study of NHANES 1999-2004

  Front Nutr. 2024 Jun 18:11:1412031.

• Characterizing neck pain during headache among people with migraine: Multicountry results from the Chronic Migraine Epidemiology and Outcomes – International (CaMEO-I) cross-sectional study

  Headache. 2024 Jul-Aug;64(7):750-763.

• Plain Language Summary Publication: The 2023 protocol for update to acute treatment of adults with migraine in the emergency department: The American headache society evidence assessment of parenteral pharmacotherapies

  Headache. 2024 Jul-Aug;64(7):901-902.

• Medication “underuse” headache

  . 2024 Cephalalgia.Apr;44(4):3331024241245658.

• Vestibular migraine: an update

  Curr Opin Neurol. 2024 Apr 16.

• Safety and tolerability of monoclonal antibodies targeting the CGRP pathway and gepants in migraine prevention: A systematic review and network meta-analysis

Cephalalgia. February 14, 2023

• The effect of simultaneous administration of occipital nerve block and cervical myofascial trigger point injection (MTrPI) on headache parameters in chronic migraine patients

  Ir J Med Sci. 2024 Mar 7.

• Calcitonin gene-related peptide-targeting therapies are a first-line option for the prevention of migraine: An American Headache Society position statement update

  Headache. 2024 Mar 11.

• Comparing Migraine Headache Index vs. Monthly Migraine Days Following Nerve Deactivation for Headache: A Systematic Review and Meta-Analysis

  Plast Reconstr Surg. 2023 Jun 6.

• Two-year, real-world erenumab persistence and quality of life data in 82 pooled patients with abrupt onset, unremitting, treatment refractory headache and a migraine phenotype: New daily persistent headache or persistent post-traumatic headache in the majority of cases

  Cephalalgia. 2023 Jun;43(6):3331024231182126.

  ---

• Sex-related differences in migraine clinical features by frequency of occurrence: a cross-sectional study

  Scand J Pain. 2023 May 15.

  ---

• Efficacy of lasmiditan for the acute treatment of perimenstrual migraine
• cephalalgia,Volume 42, Issue 14

• Effectiveness of onabotulinumtoxinA (BOTOX®) for the preventive treatment of chronic migraine: A meta-analysis on 10 years of real-world data
• cephalalgia,Volume 42, Issue 14

• The role of cytokines in migraine: A systematic review
• cephalalgia,Volume 42, Issue 14

• Genetic Overlap Analysis Identifies a Shared Etiology between Migraine and Headache with Type 2 Diabetes

  Genes(Basel). 2022 Oct 12;13(10):1845.

• European Headache Federation guideline on the use of monoclonal antibodies targeting the calcitonin gene related peptide pathway for migraine prevention – 2022 update

  J Headache Pain. 2022 Jun 11;23(1):67.

• External Concurrent Occipital and Trigeminal Neurostimulation Relieves Migraine Headache: A Prospective, Randomized, Double-Blind, Sham-Controlled Trial

  Pain Ther. 2022 Sep;11(3):907-922.

• Special Issue “Migraine and Headache in Children and Adolescents”

  Life(Basel). 2022 May 8;12(5):704.

• Cranial autonomic symptoms in migraine are related to central sensitization: a prospective study of 164 migraine patients at a tertiary headache center

  BMC Neurol. 2022 Mar 14;22(1):89.

• Role of Yoga as an Adjunct in the Management of Migraine Headache-Current Status and Future Indications

  Int J Yoga. Jan-Apr 2022;15(1):12-18.

  . 2022 Mar 14;22(1):89.

• Association Between Meniere Disease and Migraine

  JAMA Otolaryngol Head Nec Surg. 2022 May 1;148(5):457-464.

• Physical Activity is Associated with Less Analgesic Use in Women Reporting Headache-A Cross-Sectional Study of the German Migraine and Headache Society (DMKG)

  Pain Ther. 2022 Feb 25.

• Computerized migraine diagnostic tools: a systematic review

  Ther Adv Chronic Dis. 2022 Jan 24;13:20406223211065235.

• Migraine Aura, Transient Ischemic Attacks, Stroke, and Dying of the Brain Share the Same Key Pathophysiological Process in Neurons Driven by Gibbs–Donnan Forces, Namely Spreading Depolarization

Frontiers in Cellular Neuroscience; Lausanne (Feb 10, 2022)

• Clinical characteristics of definite vestibular migraine diagnosed according to criteria jointly formulated by the Bárány Society and the International Headache Society

  Braz J Otorhinolaryngol. 2022 Jan 21;S1808-8694(22)00001-5.

• Associations between adherence to Mediterranean dietary pattern and frequency, duration, and severity of migraine headache: A cross-sectional study

  Nutr Neurosci. 2021 Dec 6;1-10.

• Deterioration of headache impact and health-related quality of life in migraine patients after cessation of preventive treatment with CGRP(-receptor) antibodies

  J Headache Pain. 2021 Dec 31;22(1):158.

• CGRP-targeted drugs for migraine: still many uncertainties

  Lancet Neurol. 2022 Jan 27;S1474-4422(21)00468-3.

• Non-invasive vagus nerve stimulation for prevention of migraine: The multicenter, randomized, double-blind, sham-controlled PREMIUM II trial

Cephalalgia. January 9, 2022

• Calcitonin gene-related peptide-targeting drugs for migraine: how pharmacology might inform treatment decisions

Lancet Neurol. January 27, 2022

• Pericranial Total Tenderness Score in Patients with Tension-type Headache and Migraine. A Systematic Review and Meta-analysis

  Pain Physician. 2021 Dec;24(8):E1177-E1189.

• Altered brain network functional connectivity patterns in patients with vestibular migraine diagnosed according to the diagnostic criteria of the Bárány Society and the International Headache Society

  . 2021 Nov 18.

• Preventive migraine treatment with eptinezumab reduced acute headache medication and headache frequency to below diagnostic thresholds in patients with chronic migraine and medication-overuse headache

  Headache. 2021 Sep 22.

• CGRP antibody therapy in patients with drug resistant migraine and chronic daily headache: a real-world experience

  J Headache Pain. 2021 Sep 20;22(1):111.

• Dietary alteration of n-3 and n-6 fatty acids for headache reduction in adults with migraine: randomized controlled trial

  BMJ. 2021 Jun 30;374:n1448.

• Prescribing for pregnancy: managing chronic headache and migraine

  Drug Ther Bull. 2021 Aug 19;dtb-2021-000031.

• Is there a relationship between dietary sodium and potassium intake and clinical findings of a migraine headache?

  Br J Nutr. 2021 Aug 11;1-28.

• Instrumental assessment of physiotherapy and onabolulinumtoxin-A on cervical and headache parameters in chronic migraine

  Neurol Sci. 2021 Aug 5.

• Effects of Intravenous Eptinezumab vs Placebo on Headache Pain and Most Bothersome Symptom When Initiated During a Migraine Attack: A Randomized Clinical Trial

  JAMA. 2021 Jun 15;325(23):2348-2356.

• Association Between Dietary Iron Intake and Serum Ferritin and Severe Headache or Migraine

  Front Nutr. 2021 Jul 6;8:685564.

• The American Headache Society Consensus Statement: Update on integrating new migraine treatments into clinical practice

  Headache. 2021 Jun 23.

• Real-life assessment of erenumab in refractory chronic migraine with medication overuse headache

  Neurol Sci. 2021 Jul 5.

• A narrative review of the importance of pharmacokinetics and drug-drug interactions of preventive therapies in migraine management

  Headache. 2021 Jun;61(6):838-853.

• Increased GABA+ in people with migraine, headache and pain conditions- a potential marker of pain

J Pain. 2021 Jun .

• Shorter visual aura characterizes young and middle-aged stroke patients with migraine with aura

  J Neurol. 2021 Jun 24.

• Randomised, controlled trial of erenumab for the prevention of episodic migraine in patients from Asia, the Middle East, and Latin America: The EMPOwER study.
  

  Cephalalgia.2021 Jun

  ---

  Thalamo-cortical networks in subtypes of migraine with aura patients

J Headache Pain. 2021 Jun 19;22(1):58.

• Migraine Is More Than Just Headache: Is the Link to Chronic Fatigue and Mood Disorders Simply Due to Shared Biological Systems?

Front Hum Neurosci. 2021 Jun

• Clinical and Neurophysiological Effects of Botulinum Neurotoxin Type A in Chronic Migraine

Toxins (Basel). 2021 May 29;13(6):392.

• Voxel-based quantitative susceptibility mapping revealed increased cerebral iron over the whole brain in chronic migraine

Mol Pain. Jan-Dec 2021;17:17448069211020894.

• Efficacy of calcitonin gene-related peptide (CGRP) receptor blockers in reducing the number of monthly migraine headache days (MHDs): A network meta-analysis of randomized controlled trials

J Neurol Sci. 2021 May 21;427:117505.

• InterMiG: international differences in the therapeutic approach to migraine patients in specialized headache centersJ Headache Pain. 2021 May 24;22(1):43.

• Withdrawal failure in patients with chronic migraine and medication overuse headache.Acta Neurol Scand. 2021 May 25.

• Social and emotional cognition in patients with severe migraine consulting in a tertiary headache center: A preliminary studyRev Neurol (Paris). 2021 Jan 13;S0035-3787(20)30755-4.

• Guidelines of the International Headache Society for clinical trials with neuromodulation devices for the treatment of migraineCephalalgia. 2021 May 14;3331024211010413.

• Burden and attitude to resistant and refractory migraine: a survey from the European Headache Federation with the endorsement of the European Migraine & Headache AllianceJ Headache Pain. 2021 May 18;22(1):39.

• Real-World Treatment Profiles, Clinical Outcomes, and Healthcare Resource Utilization of Patients with Migraine Prescribed Erenumab: A Multicenter Chart-Review Study of US Headache CentersNeurol Ther. 2021 Apr 15.

• Strange Bedfellows: Migraine Headache and Patent Foramen OvaleAm J Med. 2021 Apr 20;S0002-9343(21)00221-7.

• Association between suicidal risks and medication-overuse headache in chronic migraine: a cross-sectional studyJ Headache Pain. 2021 May 10;22(1):36.

• Watermelon and others plant foods that trigger headache in migraine patientsPostgradbMed. 2021 Apr 23.

• Erenumab for the preventive treatment of chronic migraine complicated with medication overuse headache: an observational, retrospective, 12-month real-life studyNeurol Sci. 2021 Feb 5.

• Chronic migraine with daily headache. Literature review